Success Stories: EB-1A Approved for an Assistant Professor in California in the Field of Pharmaceutics
Client’s Testimonial:
Thank you so much for the great news. I will definitely recommend your firm on Linkedin and facebook.
On February 27th, 2015, We Received Another EB1-A (Alien of Extraordinary Ability) Approval for an Assistant Professor in the Field of Pharmaceutics (Approval Notice)
Position at the Time of Case Filing: Assistant Professor
Country of Origin: India
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: California
Approval Notice Date: February 27th, 2015
Processing Time: 2 months, 17 days (4 days after Requesting Premium Processing)
In this case, the client that we had the opportunity to work with was an assistant professor from India in the field of pharmaceutics. He had conducted his research in the highly specialized area of novel drug delivery method enhancement, as well as in the validation of new clinical applications for existing pharmaceutical compounds. His work had resulted in 20 peer-reviewed scientific articles, 2 additional journal articles accepted for publication, 1 book chapter, 1 patent, and numerous presentations at national and international conferences; at the time that his case was filed, his publications had been cited at least 326 times by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of his work. He had also reviewed 40 manuscripts and approximately 100 conference abstracts for distinctive, internationally-circulated journals and conferences. His superior level of expertise was confirmed in the following quote from an independent recommender, “[Client’s] record of success in drug delivery projects and established experimental procedures prove his standing as one of the top researchers in pharmaceutical sciences, as well as provide the evidence that his future projects will continue to provide relief to the 19 million diabetic patients of the entire country.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of pharmaceutics, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in 2 months and 17 days (4 days after Requesting Premium Processing).